Additional information
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg+5mg, 10mg+10mg |
Price range: $54.40 through $80.00 SAVE 20%
-20%This research-grade blend combines two structurally and mechanistically distinct peptides studied for their complementary roles in tissue biology. BPC-157 (Body Protection Compound-157) is a stable synthetic pentadecapeptide derived from human gastric juice protein, extensively investigated for its cytoprotective, organoprotective, and vascular-modulating properties in preclinical models. TB-500 is a synthetic fragment corresponding to the active region of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein that functions as the primary intracellular G-actin sequestering peptide, with well-documented roles in cell migration, extracellular matrix remodeling, and tissue repair signaling. Research compound — for laboratory use only.
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg+5mg, 10mg+10mg |
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.